IMPACT OF ACNE VULGARIS ON A PERSON’S QUALITY OF LIFE AND IT’S CORRELATION WITH THE CLINICAL SEVERITY PRE AND POST-DRUG THERAPY

SWOPNA PHUKAN; SAHELI DAS

doi:10.22159/ijpps.2022v14i1.43256

Authors

SWOPNA PHUKAN Department of Pharmacology, Diphu Medical College, Diphu 782462
SAHELI DAS Department of Pharmacology, Gauhati Medical College, Guwahati 781032 https://orcid.org/0000-0001-7544-0295

DOI:

https://doi.org/10.22159/ijpps.2022v14i1.43256

Keywords:

Acne vulgaris, GAGS score, Quality of life, CADI score

Abstract

Objective: The aim of the study is to assess the therapeutic efficacy of drugs used in acne vulgaris by measuring the severity of acne using the Global Acne Grading System score (GAGS) and Cardiff Acne Disability Index (CADI) questionnaire score pre and post-drug therapy.

Methods: The present study was conducted in the Department of Dermatology after getting approval from the Institutional Ethics Committee (No MC/190/2007/Pt1/MAR-2019/PG/123) dated 10/04/2019. It was an observational study for a period of 1 y. 172 patients were enrolled in the study. Patients were divided into 4 grades depending on their clinical manifestation. The severity of acne vulgaris and the quality of life were measured using the GAGS scale and the CADI questionnaire, respectively at the first visit and at the follow-up visit in all the grades of acne vulgaris. A correlation was done between the GAGS and the CADI score at the follow-up visit in all grades of acne.

Results: It was observed that the GAGS score and the CADI score was significantly improved at the F/U visit (p<0.05) as compared to baseline in all the 4 grades of acne. A correlation between GAGS score and QoL using CADI scale was done using Pearson Parametric Correlation Test. In none of the groups, the correlation was significant (p>0.05).

Conclusion: We can conclude from our study that following treatment with drugs, the clinical severity of acne decreased and there was also a significant improvement in the quality of life of patients.

Downloads

Download data is not yet available.

References

Burton JL, Cunliffe WJ, Stafford I, Shuster S. The prevalence of acne vulgaris in adolescence. Br J Dermatol. 1971;85(2):119-26. doi: 10.1111/j.1365-2133.1971.tb07195.x, PMID 4255129.

Kucharska A, Szmurło A, Sinska B. Significance of diet in treated and untreated acne vulgaris. Postepy Dermatol Alergol. 2016;33(2):81-6. doi: 10.5114/ada.2016.59146, PMID 27279815.

Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol. 2010;63(1):124-41. doi: 10.1016/j.jaad.2009.07.043, PMID 20338665.

Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1);Suppl:179S-88S. doi: 10.1093/ajcn/71.1.179S, PMID 10617969.

Thiboutot DM, Strauss JS. Diseases of sebaceous glands. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Dermatology in general Medicine. 6th ed. Vol. 1. New York: McGraw-Hill; 2003. p. 672-87.

Witkowski JA, Parish LC. From other ghosts of the past: acne lesion counting. J Am Acad Dermatol. 1999;40(1):131. doi: 10.1016/s0190-9622(99)70552-9, PMID 9922034.

Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and a proposal of a novel system. Int J Dermatol. 1997;36(6):416-8. doi: 10.1046/j.1365-4362.1997.00099.x, PMID 9248884.

Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131(2):363-70. doi: 10.1038/jid.2010.264, PMID 20844551.

Prasad. Acne vulgaris: a review on pathophysiology and treatment. Asian J Pharm Clin Res. 2016;9(4):54-9.

Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17(1):1-3. doi: 10.1111/j.1365-2230.1992.tb02521.x, PMID 1424249.

Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol. 1997;136(1):66-70. doi: 10.1046/j.1365-2133.1997.d01-1144.x’, PMID 9039297.

who.int/medicines/areas/rational _use/en/. [Last accessed on 20 Aug 2021]

Cunliffe WJ, Simpson NB. Disorders of sebaceous glands. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rooks textbook of dermatology. 6th ed. Vol. 3. Oxford: Blackwell Publishing Science; 1998. p. 1927-84.

Burton JL, Shuster S. The relationship between seborrhoea and acne vulgaris. Br J Dermatol. 1971;84(6):600-2. doi: 10.1111/j.1365-2133.1971.tb02553.x, PMID 4254112.

James WD, Berger TG, Elston DM. Andrew’s diseases of the skin, Clinical. 9th ed. Philadelphia: Saunders. Dermatology; 2000.

Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol. 1984;111(1):83-92. doi: 10.1111/j.1365-2133.1984.tb04020.x, PMID 6234917.

Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch Dermatol. 1979;115(5):571-5, PMID 156006.

Michaelson G, Juhlin L, Vahlquist A. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol. 1977;57(4):372. PMID 70937.

Lucchina LC, Kollias N, Phillips SB. Quantitative evaluation of non-inflammatory acne with fluroscence photography. J Invest Dermatol. 1994;102:560.

Phillips SB, Kollias N, Gillies R, Muccini JA, Drake LA. Polarized light photography enhances visualization of inflammatory lesions of acne vulgaris. J Am Acad Dermatol. 1997;37(6):948-52. doi: 10.1016/s0190-9622(97)70070-7, PMID 9418762.

Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide-releasing therapies as antimicrobial agents. Virulence. 2012;3(3):271-9. doi: 10.4161/viru.20328, PMID 22546899.

Chu TC. Acne and other facial eruptions. Medicine. 1997;25:30-3.

Gupta MA, Johnson AM, Gupta AK. The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol. 1998;78(6):451-6. doi: 10.1080/000155598442773, PMID 9833047.

Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales--a measure of the impact of skin diseases. Br J Dermatol. 1997;136(2):202-6. PMID 9068732.

Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707-13. doi: 10.1111/1523-1747.ep12365600, PMID 8875954.

Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83. doi: 10.1097/00005650-199206000-00002. PMID 1593914.